
CTI BioPharma Investor Relations Material
Latest events

Q4 2022
CTI BioPharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CTI BioPharma Corp
Access all reports
CTI BioPharma Corp. is a biopharmaceutical company focused on the development and commercialization of novel therapies for blood-related cancers. The company’s lead product is designed to treat patients with rare blood cancers, such as myelofibrosis. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.
Latest articles
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
Ticker symbol
CTIC
Country
🇺🇸 United States